Curis
CRIS
#10257
Rank
NZ$38.6 M
Marketcap
NZ$0.97
Share price
3.17%
Change (1 day)
-59.76%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.45. In 2024 the company made an earnings per share (EPS) of NZ-$12.35 an increase over its 2023 EPS that were of NZ-$15.86.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-48.3%
2024NZ-$12.35-22.15%
2023NZ-$15.86-26.17%
2022NZ-$21.4822.3%
2021NZ-$17.56-25.37%
2020NZ-$23.53-30.93%
2019NZ-$34.07-2.02%
2018NZ-$34.77
2016NZ-$79.03-10%
2015NZ-$87.81138.1%
2014NZ-$36.8840%
2013NZ-$26.34-25%
2012NZ-$35.1266.67%
2011NZ-$21.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.39-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.08-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.63-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$5.08-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$6.83 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$19.74 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.48-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA